Manufacturers should expect multiple pricing ... ONO-4538). Abstract CRA9006, ASCO 2013. 2. Ribas et al., 2013. Clinical efficacy and safety of lambrolizumab (MK-3475, Anti-PD-1 monoclonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results